Related Experiment Video
Updated: Jun 5, 2026
08:31
Anaerobic Protein Purification and Kinetic Analysis via Oxygen Electrode for Studying DesB Dioxygenase Activity and Inhibition
Published on: October 3, 2018
Metabolic pathways of ochratoxin A
Qinghua Wu1, Vlastimil Dohnal, Lingli Huang
1MOA Key Laboratory of Food Safety Evaluation / National Reference Laboratory of Veterinary Drug Residues (HZAU), Huazhong Agricultural University, Wuhan, Hubei 430070, People's Republic of China.
Current Drug Metabolism
|January 13, 2011
Summary
Ochratoxin A (OTA) is a food contaminant with toxic effects. Understanding its metabolism in humans, animals, and plants is crucial for food safety and risk assessment.
Area of Science:
- Food Science
- Toxicology
- Microbiology
Background:
- Ochratoxin A (OTA) is a carcinogenic (Group 2B) mycotoxin contaminating foodstuffs.
- OTA exhibits nephrotoxic, hepatotoxic, teratogenic, and immunotoxic properties.
- It is implicated in Balkan Endemic Nephropathy (BEN) when ingested with citrinin.
Purpose of the Study:
- To review the metabolism of Ochratoxin A (OTA) across various organisms.
- To understand the biotransformation of OTA for improved food safety and risk assessment.
- To elucidate the metabolic pathways and resulting metabolites of OTA.
Main Methods:
- Review of scientific literature on Ochratoxin A (OTA) metabolism.
- Analysis of metabolic pathways in humans, animals, plants, fungi, yeast, and bacteria.
- Identification of key metabolites and their toxicological significance.
Main Results:
- Major metabolic pathways include hydrolysis, hydroxylation, lactone-opening, and conjugation.
- OTalpha (OTα) is a common, non-toxic metabolite across organisms.
- Other metabolites like OP-OTA, hydroxylated forms (e.g., 4R-OH-OTA), and conjugates are identified, with varying toxicity.
Conclusions:
- Understanding OTA metabolism is vital for assessing its risks to human health.
- Biotransformation into less toxic forms, like OTα, offers potential for mycotoxin control.
- This review provides critical insights for toxicology and food safety evaluations of OTA.
Related Concept Videos
01:26Respiration Pathways
Cellular respiration is a fundamental metabolic process that enables organisms to generate energy from organic molecules. One of its central pathways is the tricarboxylic acid (TCA) cycle, also known as the Krebs cycle, which plays a crucial role in energy production and biosynthetic processes.Conversion of Pyruvate to Acetyl-CoAThe pyruvate generated from glycolysis undergoes oxidative decarboxylation by the pyruvate dehydrogenase complex, producing acetyl-CoA, one molecule of NADH, and one...
01:19Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
01:29Amino Acid Biosynthetic Pathways
Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which provide...
01:21Toxicokinetics: Overview
Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
01:19Phase I Oxidative Reactions: Overview
Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
01:17Drug Metabolism: Phase I Reactions
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...